Anlage DmMV

Anabol-androgene Steroide | | nicht geringe Menge | | --- | --- | | Androst-4-en-3,11,17-trion | 3 000 mg | | Androstanolon, synonym Dihydrotestosteron | 1 500 mg | | 1-Androstendiol | 3 000 mg | | Androstendiol | 3 000 mg | | 1-Androstendion | 3 000 mg | | Androstendion | 3 000 mg | | 1-Androsteron | 3 000 mg | | Bolasteron | 100 mg | | Boldenon | 1 000 mg | | Boldion | 3 000 mg | | Calusteron | 100 mg | | Clostebol | | | – parenterale Darreichungsformen | 80 mg | | – andere Darreichungsformen | 900 mg | | Danazol | 3 000 mg | | Dehydrochlormethyltestosteron | 100 mg | | Desoxymethyltestosteron | 100 mg | | Drostanolon | 1 015 mg | | Epistan | 100 mg | | Ethylestrenol | 450 mg | | Fluoxymesteron | 100 mg | | Formebolon | 100 mg | | Furazabol | 100 mg | | Gestrinon | 45 mg | | 4-Hydroxytestosteron | 1 500 mg | | Mestanolon | 100 mg | | Mesterolon | 1 500 mg | | Metandienon | 100 mg | | Metenolon | | | – parenterale Darreichungsformen | 150 mg | | – andere Darreichungsformen | 1 500 mg | | Methandriol | 100 mg | | Methasteron | 100 mg | | Methyldienolon | 45 mg | | Methyl-1-testosteron | 100 mg | | Methylnortestosteron | 100 mg | | Methylstenbolon | 100 mg | | Methyltestosteron | 100 mg | | Metribolon, synonym Methyltrienolon | 45 mg | | Miboleron | 100 mg | | Nandrolon | 150 mg | | 19-Norandrostendion | 3 000 mg | | Norboleton | 450 mg | | Norclostebol | 1 500 mg | | Norethandrolon | 450 mg | | Oxabolon | 75 mg | | Oxandrolon | 100 mg | | Oxymesteron | 100 mg | | Oxymetholon | 100 mg | | Prasteron, synonym Dehydroepiandrosteron (DHEA) | | | – parenterale Darreichungsformen | 144 mg | | – andere Darreichungsformen | 3 000 mg | | Prostanozol | 1 500 mg | | Quinbolon | 1 500 mg | | Stanozolol | 100 mg | | Stenbolon | 1 500 mg | | 1-Testosteron | 1 500 mg | | Testosteron | | | – transdermale oder orale Darreichungsformen | 1 500 mg | | – andere Darreichungsformen | 632 mg | | Tetrahydrogestrinon | 45 mg | | Tibolon | 225 mg | | Trenbolon | 150 mg | | Andere mit anabol-androgenen Steroiden verwandte Stoffe | | | – mit 17alpha-Methyl-Struktur | 100 mg | | – mit anderen Strukturen | 3 000 mg |

Andere anabole Stoffe | | nicht geringe Menge | | --- | --- | | Clenbuterol | 5,4 mg | | Osilodrostat | 5 400 mg | | Selektive Androgen-Rezeptor-Modulatoren (SARMs) | 540 mg | | Zum Beispiel: | | | Andarin (S-4) | | | Ligandrol (LGD-4033, VK 5211) | | | Ostarin, synonym Enobosarm (S-22, MK-2866) | | | RAD-140, synonym Testolon | | | S-23 | | | YK-11 | | | Zeranol | 4,5 mg | | Zilpaterol | 4,5 mg |

Erythropoese stimulierende Stoffe | | nicht geringe Menge | | --- | --- | | Erythropoetin human (EPO) | 24 000 IE | | Epoetin alfa, beta, delta, omega, theta, zeta und analoge rekombinante humane Erythropoetine | | | Darbepoetin alfa (dEPO) | 120 µg | | Methoxy-Polyethylenglycol-Epoetin beta, synonym PEG-Epoetin beta, Continuous Erythropoiesis Receptor Activator (CERA) | 90 µg | | Peginesatid, synonym Hematid | 5 mg | | Hypoxie-induzierbarer-Faktor (HIF)-Aktivatoren | 15 600 mg | | Zum Beispiel: | | | Daprodustat (GSK1278863) | | | Molidustat | | | Roxadustat (FG-4592) | | | Vadadustat (AKB-6548) | |

Peptidhormone und ihre Releasingfaktoren

Choriongonadotropin (CG) und Luteinisierendes Hormon (LH) sowie ihre Releasingfaktoren | | nicht geringe Menge | | --- | --- | | Buserelin | 168 mg | | Choriongonadotropin (HCG) | 65 000 IE | | Choriongonadotropin alfa | 750 µg | | Deslorelin | 4,5 mg | | Gonadorelin | 40 mg | | Goserelin | 10,8 mg | | Leuprorelin | 30 mg | | Lutropin alfa | 2 250 IE | | Nafarelin | 24 mg | | Triptorelin | | | – Injektionslösung | 8,6 mg |

Corticotropine | | nicht geringe Menge | | --- | --- | | Corticotropin | 1 200 IE | | Tetracosactid | | | – retardierte parenterale Darreichungsformen | 12 mg | | – andere parenterale Darreichungsformen | 3 mg |

Wachstumshormon (-Analoga und -Fragmente), Releasingfaktoren und Releasingpeptide | | nicht geringe Menge | | --- | --- | | Lonapegsomatropin | 673 mg | | Somapacitan | 104 mg | | Somatrogon | 600 mg | | Somatropin, synonym Wachstumshormon human, Growth Hormone (GH) | 16 mg | | Somatrem, synonym Somatotropin (methionyl), human | 16 mg | | Wachstumshormon-Fragmente | 16 mg | | Zum Beispiel: | | | AOD-9604 | | | hGH-Fragment 176-191 | |

Aromatasehemmer | | nicht geringe Menge | | --- | --- | | Aminoglutethimid | 30 000 mg | | Anastrozol | 90 mg | | Androsta-3,5-dien-7,17-dion, synonym Arimistan | 4 500 mg | | Androsta-1,4,6-trien-3,17-dion, synonym Androstatriendion | 3 000 mg | | 4-Androsten-3,6,17-trion, synonym 6-oxo | 6 000 mg | | Exemestan | 2 250 mg | | Formestan | 600 mg | | Letrozol | 225 mg | | Testolacton | 90 000 mg |

Antiestrogene Stoffe | | nicht geringe Menge | | --- | --- | | Clomifen | 1 500 mg | | Cyclofenil | 4 200 mg | | Fulvestrant | 2 000 mg | | Raloxifen | 5 400 mg | | Tamoxifen | 3 600 mg | | Toremifen | 5 400 mg |

Myostatinfunktionen verändernde Stoffe | | nicht geringe Menge | | --- | --- | | Follistatin und seine Derivate | 450 mg | | Stamulumab | 450 mg |

Stoffwechsel-Modulatoren | | nicht geringe Menge | | --- | --- | | Insuline | 1 800 IE | | PPARδ (Peroxisome Proliferator Activated Receptor Delta)-Agonisten, synonym PPAR-delta-Agonisten | 225 mg | | Zum Beispiel: | | | GW501516, synonym GW1516, Cardarin, Endurobolon | | | AMPK (PPARδ–AMP-activated protein kinase)-Axis-Agonisten | 7 000 mg | | Zum Beispiel: | | | AICAR | | | Meldonium | 42 000 mg | | SR9009, synonym Stenabolic | 75 mg |